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1Introduction
Aortic stenosis (AS) is a highly and increasingly prevalent 
condition that has become a major health concern.1) Characteris-
tically, patients present a long latent asymptomatic period 
where the risk of sudden death is low, even with severe AS: i.e., 
peak aortic velocity ≥ 4 m/s, mean aortic gradient ≥ 40 mmHg 
and aortic valve area ≤ 1.0 cm2 or ≤ 0.60 cm2/m2. However, the 
risk of sudden death increases dramatically when symptoms ap-
pear justifying the European Society of Cardiology/European 
Association of Cardiothoracic Surgery (ESC/EACTS) to under-
line the role of exercise testing to clarify symptomatic status in 
patients with severe AS.2) On the other side, “truly” asymptom-
atic patients undergoing early aortic valve replacement (AVR) 
may have better outcome compared to medically treated pa-
tients.3) Hence, the determination of individual risk factors of 
rapid clinical deterioration could help identify patients who 
may benefit most from early elective surgery. Accordingly, re-
cent studies have demonstrated that exercise echocardiography 
can provide incremental prognostic value over resting echocar-
diography and exercise testing.4-6) Exercise echocardiography is 
useful because it allows assessing clinical, hemodynamic and 
functional adaptation responses during exercise, which are di-
rectly linked to functional status, degree of ventriculo-arterial 
coupling and left ventricular (LV) myocardial reserve. The pur-
pose of this article is to describe the role of exercise testing and 
echocardiography in the management of asymptomatic patients 
with severe AS and preserved LV ejection fraction.
Exercise Testing
Protocol
A complete clinical evaluation to rule out the presence of 
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symptoms and to identify potential contraindications is essen-
tial before submitting patients to exercise testing. Contraindica-
tions to exercise testing include: clear indications for AVR (i.e., 
symptomatic severe AS), uncontrolled hypertension (systolic 
pressure > 220 mmHg or diastolic pressure > 110 mmHg), un-
controlled or symptomatic arrhythmias, physical or mental dis-
ability with the inability to adequately exercise and systemic 
disease limiting exercise performance.7) A symptom-limited 
exercise test performed with the goal to reach at least 85% of 
the age-predicted heart rate is recommended. Treadmill or 
semi-supine bicycle exercise testing can be used. Safety of 
both techniques has already been demonstrated and complica-
tions remain low under appropriate supervision and monitor-
ing.8)9) Treadmill exercise is more commonly used in North 
America and is realized according to the ACC/AHA practice 
guidelines using a modified Bruce protocol.10) In contrast, semi-
supine ergometer with a tilting table is the preferred approach 
in Europe reducing the potential risk of hemodynamic col-
lapse compared to treadmill test.11) Patients should continue 
their usual medications, as abnormal results on suboptimal 
therapy may be confusing for management decisions. The 
workload should be adjusted for each patient, i.e., beginning 
at 50 W with an increase of 25 W every 2 minutes for a young 
patient versus starting at 25 W with an increase of 10 W ev-
ery 2 minutes for an older patient. Appearance of symptoms 
should be assessed regularly, and blood pressure, heart rate and 
12-lead electrocardiography should be monitored continuously 
during the examination. Exercise testing should be interrupted 
when the target heart rate is reached or if the patient presents 
typical chest pain, limiting breathlessness, dizziness, hypoten-
sion (drop in systolic blood pressure ≥ 20 mmHg), significant 
ventricular arrhythmia or muscular exhaustion.
Interpretation
Symptomatic status can be difficult to establish because pa-
tients may minimize or deny their symptoms or reduce their 
level of physical activity to avoid them, especially in elderly. 
Then, exercise testing can be useful to unmask symptoms in pa-
tients with severe AS. Approximately one third of patients who 
claim to be asymptomatic will develop symptoms on exercise 
testing.12)13) However, the occurrence of rapidly reversible dys-
pnea at high workloads should not be interpreted as abnormal. 
Interpretation of exercise testing could be limited in elderly 
population. In fact, positive predictive value in patients > 70 
years old has been shown to be significantly lower than in 
younger patients (56% compared to 79%) with similar nega-
tive predictive values.13) According to this, a negative exercise 
test should be reassuring, but a positive exercise test may lack of 
specificity due to frequent comorbidities in elderly patients. 
Also, ST segment depression may not improve the positive pre-
dictive value of exercise testing, particularly in patients with 
concomitant coronary artery disease.13) Generally, exercise test-
ing is considered positive when the patient presents ≥ 1 of the 
following criteria: angina, limiting dyspnea at low workloads, 
syncope or near-syncope, ≥ 2 mm horizontal or down-slopping 
ST segment depression, drop or ≥ 20 mmHg rise in systolic 
blood pressure or complex ventricular arrhythmias.7)
Impact on clinical decision-making
Symptom-limited exercise testing can add important prog-
nostic value.14) For this reason, exercise testing is strongly advo-
cated by the ESC/EACTS (Class I recommendation) in asymp-
tomatic patients with severe AS.2) In fact, a positive exercise test 
has been shown to predict the rapid onset of symptoms, the oc-
currence of cardiac death and the need for AVR. To note, exer-
cise-induced dizziness have the highest positive predictive value 
for the occurrence of symptoms during follow-up.12) In a meta-
analysis examining 491 patients, a negative exercise test was as-
sociated with no sudden death while 5% of patients with a pos-
itive result presented with sudden death during 12-month 
follow-up. Also, 21% of patients with a negative exercise test 
had adverse cardiac events compared to 66% of patients with a 
positive result.14) Therefore, current ESC/EACTS guidelines rec-
ommend AVR in asymptomatic patients with severe AS who 
develop symptoms during exercise testing (ESC/EACTS, Class 
I) or a fall in systolic blood pressure below baseline value (ESC/
EACTS, Class IIa) (Fig. 1).2)
Exercise Echocardiography
Protocol
In valvular heart disease, an experienced sonographer or car-
diologist should perform exercise echocardiography. Both 
types of exercise test can be used. Treadmill allows only post-
exercise imaging limiting the accuracy of measurements com-
pared to semi-supine cyclo-ergometer permitting optimal im-
age acquisitions during each step of exercise testing. Comp-
rehensive resting echocardiography should be performed in 
the same position as during the exercise testing. Echocardio-
graphic parameters related to the severity of AS, the conse-
quences on the LV and the systolic pulmonary arterial pressure 
(SPAP) should be recorded throughout the test. To note, the 
ratio of early diastolic mitral inflow velocity to early diastolic 
annulus velocity (E/e’ ratio) should be measured before E and 
A wave fusion appearing at higher heart rates (usually > 100–
110 bpm) (Fig. 2).
Interpretation
Changes in mean aortic gradient
Regardless of resting AS severity, an increase in mean aortic 
pressure gradient by ≥ 18–20 mmHg during exercise, which 
occur in about one-third of patients, is associated with an in-
creased risk of cardiac-related events.4)6) In fact, an exercise-in-
duced increase in mean aortic pressure gradient by ≥ 20 
mmHg has been identified as the most powerful predictor of 
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poor outcomes, even after adjustment for age, exercise LV ejec-
tion fraction and resting mean aortic gradient.6) Such an in-
crease in mean aortic pressure gradient partly reflects the pres-
ence of a rigid and non-compliant aortic valve.15) Moreover, the 
kinetics of change in mean aortic pressure gradient needs to be 
assessed as a rapid increase may indicate the presence of a more 
severe disease.
LV systolic functional reserve
Assessment of LV function during exercise can also provide 
incremental prognostic information. Limited contractile reserve 
(i.e., a decrease or a limited increase in LV ejection fraction) has 
been shown to be associated with an abnormal hemodynamic 
response to exercise, the development of symptoms and cardio-
vascular death.16)17) Limited contractile reserve may represent a 
more advanced disease process with subclinical intrinsic myo-
cardial damage. The afterload mismatch and the exhausted cor-
onary flow reserve with consequent subendocardial ischemia 
and myocardial fibrosis could contribute to limited functional 
LV adaptation during test.18) As previously reported, standard 
LV ejection fraction measurements are relatively insensitive to 
detect early forms of myocardial dysfunction and assessment of 
LV longitudinal function seems to be more powerful in predict-
ing the occurrence of symptoms, exercise intolerance and out-
come in AS.19)20) Longitudinal function can be studied using tis-
sue Doppler imaging with pulsed-wave Doppler at the mitral 
annulus measuring s’ velocities or using 2-dimentional speckle 
tracking analyzing global longitudinal strain (GLS) (Fig. 3). In 
a cohort of AS patients, a smaller increase in s’ velocities after 
exercise was associated with a lower exercise capacity and a low-
er exercise-induced increase in systolic blood pressure.21) Accord-
ing to strain analysis, Lafitte et al.19) demonstrated that patients 
Fig. 1. Impact on clinical decision-making of exercise testing and exercise echocardiography in asymptomatic patients with severe aortic stenosis 
and preserved left ventricular function. MG: mean aortic pressure gradient, AVA: aortic valve area, BP: blood pressure, EF: ejection fraction, SPAP: 
systolic pulmonary artery pressure, ESC: European Society of Cardiology.
Fig. 2. Exercise echocardiography protocol including the sequence of acquisition. *Should be measured at low-level exercise before E and A wave 
fusion. CW: continuous-wave Doppler, fps: frame per second, LV: left ventricle, PW: pulsed-wave Doppler, SPAP: systolic pulmonary artery pressure, 
TDI: tissue Doppler imaging, TR: tricuspid regurgitation.  
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with an abnormal exercise response had a significant lower rest-
ing GLS and basal longitudinal strain (BLS) compared to pa-
tients with a normal exercise test (respectively -14.7% vs. 
-19.3% and -10.7% vs. -14.4%). Cutoff values of -18% for 
GLS and -13% for BLS were able to predict an inadequate exer-
cise response with a sensitivity/specificity of 68/75% (GLS) and 
77/83% (BLS). Moreover, Donal et al.22) reported that exer-
cise-induced changes in LV GLS were lower in AS patients 
with an abnormal exercise response. In multivariable analysis, a 
lower resting GLS, a higher exercise-induced increase in mean 
aortic pressure gradient and a smaller exercise-induced change 
in GLS were predictors of a positive exercise test.
LV diastolic functional reserve
In patients with severe AS, the chronically increased after-
load is compensated by LV hypertrophy. At a later stage, this 
adaptive response may be no longer sufficient to mitigate the 
clinical impact of an increase in LV filling pressure. The E/e’ 
ratio is recognized as a noninvasive estimate of LV filling pres-
sure. At rest, a cutoff value of E/e’ > 13 has been shown to iden-
tify LV end-diastolic pressure > 15 mmHg with a sensitivity of 
93% and a specificity of 88%.23) At exercise, cutoff values of E/e’ 
between 13 and 15 were correlated with elevated LV end-dia-
stolic pressure during exercise and reduced exercise capacity in 
patients without valvular disease.24)25) However, these exercise 
values have not been validated in AS patients.
Changes in systolic pulmonary artery pressure
In asymptomatic patients, exercise echocardiography may 
unmask dynamic pulmonary hypertension (PHT). In fact, an 
early exercise-induced increase in SPAP is in favour of a lack of 
pulmonary vascular adaptation with a high resistance and a 
low compliance reflecting a more severe disease. In a recent 
prospective study, exercise-induced PHT, defined as SPAP > 
60 mmHg, was associated with a 2-fold increase risk of cardi-
ac events at 3-year follow-up in asymptomatic patients with 
severe AS and preserved LV ejection fraction. Also, in multi-
variable model, exercise PHT was identified as an indepen-
dent predictor of cardiac events, even when exercise-induced 
changes in mean aortic gradient were added.5)
Impact on clinical decision-making
Because of its incremental prognostic value, exercise echo-
cardiography may be useful to improve risk stratification and 
identify patients who may benefit from an early surgery. Ac-
cording to this, the ESC/EACTS recently added a recommen-
dation based on exercise echocardiography. In asymptomatic 
patients with severe AS and preserved LV ejection fraction, 
AVR may be considered in patients with an exercise-induced 
increase in mean aortic pressure gradient > 20 mmHg (Class 
IIb).2) Otherwise, patients with a significant increase in mean 
aortic pressure gradient, a limited LV contractile reserve or 
PHT during exercise could be referred to a dedicated Heart 
Valve Clinic for a closer follow-up (3–6 months) including re-
evaluation of symptoms and repeated exercise echocardiogra-
phy.26) Conversely, patients without markers of poor prognosis 
may be safely reassessed every 12 months (Fig. 1). However, 
prospective clinical trials are needed to support the widespread 
use of exercise echocardiography in the routine management 
of asymptomatic AS.
Conclusion
In AS, exercise echocardiography can help unmask falsely 
asymptomatic patients as well as patients with abnormal he-
modynamic and functional adaptation to exercise who may 
benefit from early elective AVR. Large-scale studies are need-
ed to examine the impact of exercise echocardiography results 
on post-operative outcome.
Fig. 3. Example of an asymptomatic patient with severe aortic stenosis 
presenting a significant exercise-induced increase in mean trans-aortic 
pressure gradient (A) and exercise pulmonary hypertension (B). In 
addition, a significant exercise-induced increase in estimated left 
ventricular filling pressure (C) but a normal contractile reserve assessed 
by 2-D speckle tracking analyzing global longitudinal strain (D) was 
observed. MTAG: mean aortic pressure gradient, TTG: trans-tricuspid 
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